drugset / Trial / NCT03479372
Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Double-masked, uncontrolled, multi-center, study in which participants will be randomized to one of 3 doses of topical ocular PAN 90806 administered once daily for 12 weeks.
Timeline
- Start
- 2018-04-26
- Primary completion
- 2019-05-27
- Completion
- 2019-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OSI-632 | Small molecule | — | Topical |